Superluminal Medicines

Accelerating precision in drug development.

📋 Overview of Superluminal Medicines

Founding Year

2022

Estimated Funding

$0000

Size

$0000

Locations

Boston

Primary Industry

Precision Medicine

📙 About Superluminal Medicines

Superluminal Medicines offers drug discovery and development using generative biology, chemistry, and advanced machine learning. Their platform designs and tests highly selective compounds, targeting precise protein structures to create therapeutic breakthroughs. By combining deep biological expertise with proprietary big data infrastructure, accelerating the creation of candidate-ready drugs.

💰 Recent Investors of Superluminal Medicines

Catalio Capital Management, Cooley, Investor

© 2025 Bot Memo. All Rights Reserved.

Subscribe to Bot Memo

As as subscriber, you can explore more AI startups. You also get exclusive AI market gap reports every fortnight in your inbox.*

Continue with Google *We hate spam as much as you do.